IFNAR1 and neoplasm: In contrast, depletion of IFN-β and anti-IFNAR1 antibody treatment almost completely reversed tumor regression mediated by ASNS knockdown in syngeneic mice, suggesting that other types of immune cells besides CD8+ T cells might also contribute to ASNS loss–triggered antitumor immunity.